FAM122A has been recently shown to be phosphorylated and inhibited by CHK1 in NSCLC cell lines promoting activation of PP2A/B55α, which stabilizes WEE1 leading to inhibition of CDK123. Here, PPP2R2A is linked to non-small cell lung carcinoma.